Cardionovum is planning to launch its new Sirolimus-eluting coronary stent system, Prolimus Biograde, in Q4 2012. The new Prolimus Biograde features thin-stent strut design of just 71 microns which is designed to provide uniform stent ...
Tags: Cardionovum, Sirolimus-eluting coronary stent system, clinical product
Cardionovum has started in vivo testing of its paclitaxel-coated Restore drug-eluting balloon (DEB) to evaluate drug-in-tissue concentration. The Restore DEB, including EXPRESS drug-release platform, is designed for the treatment of ...
Tags: drug-eluting balloon, clinical product, clinical trial